These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 602233)

  • 1. Personal experience with Corynebacterium parvum in human cancers.
    Israël L; Edelstein R
    World J Surg; 1977 Sep; 1(5):585-95. PubMed ID: 602233
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunochemotherapy with Corynebacterium parvum in disseminated cancer.
    Israel L
    Ann N Y Acad Sci; 1976; 277(00):241-51. PubMed ID: 187100
    [No Abstract]   [Full Text] [Related]  

  • 3. Active specific immunotherapy with tumor cells and Corynebacterium parvum: a phase I study.
    McCune CS; Patterson WB; Henshaw EC
    Cancer; 1979 May; 43(5):1619-23. PubMed ID: 376096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lasting rejection of mammary adenocarcinoma cell tumors in DBA-2 mice with intratumor injection of killed Corynebacterium parvum.
    Likhite VV; Halpern BN
    Cancer Res; 1974 Feb; 34(2):341-4. PubMed ID: 4810906
    [No Abstract]   [Full Text] [Related]  

  • 5. Bacterial cells as anti-tumour agents in man.
    Davies M
    Rev Environ Health; 1982; 4(1):31-56. PubMed ID: 6765207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I study of a multi-modal schedule with Corynebacterium parvum.
    McIntosh IH; Thynne GS; Bejrajati P; Walsh G; Greening WP
    Dev Biol Stand; 1977 Apr 13-15; 38():477-82. PubMed ID: 344102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological response in patients receiving Corynebacterium parvum therapy.
    Osborn DE; Castro JE
    Clin Oncol; 1977 Jun; 3(2):155-64. PubMed ID: 872468
    [No Abstract]   [Full Text] [Related]  

  • 8. Proceedings: Local Corynebacterium parvum therapy in early breast cancer.
    Ackroyd NW; Boak JL
    Br J Surg; 1976 Aug; 63(8):659. PubMed ID: 953485
    [No Abstract]   [Full Text] [Related]  

  • 9. Corynebacterium parvum as an immunotherapeutic anticancer agent.
    Scott MT
    Semin Oncol; 1974 Dec; 1(4):367-78. PubMed ID: 4620441
    [No Abstract]   [Full Text] [Related]  

  • 10. A randomized prospective clinical trial of adjuvant C. parvum immunotherapy in 260 patients with clinically localized melanoma (Stage I): prognostic factors analysis and preliminary results of immunotherapy.
    Balch CM; Smalley RV; Bartolucci AA; Burns D; Presant CA; Durant JR
    Cancer; 1982 Mar; 49(6):1079-84. PubMed ID: 7037155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adriamycin-combination chemotherapy with or without immune stimulation by corynebacterium parvum in metastasizing carcinoma of the breast (author's transl)].
    Mayr AC; Senn HJ; Gallmeier WM; Bruntsch U; Becher R; Drings P; Fritze D; Kaufmann M; Queisser W; Kempgens U
    Dtsch Med Wochenschr; 1979 Dec; 104(49):1739-43. PubMed ID: 510206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preliminary results of polychemiotherapy and immunostimulant treatment with Corynebacterium parvum in tumors of the breast in the postoperative phase and advanced phase].
    Bellotti R; Tauriello A; Alzetta A
    Minerva Med; 1978 Apr; 69(21):1443-54. PubMed ID: 683548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A survey of patients' reactions to intravenous Corynebacterium parvum therapy.
    Palmer BV; Walsh G; Smedley P; McIntosh IH; Greening WP
    Dev Biol Stand; 1977 Apr 13-15; 38():529-33. PubMed ID: 608547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonspecific immunotherapy of malignant tumors.
    Milas L; Withers HR
    Radiology; 1976 Jan; 118(1):211-8. PubMed ID: 1105663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoimmunotherapy in disseminated melanoma and colorectal carcinoma.
    Gough IR; Bolton PM; Clunie GJ; Burnett W
    Aust N Z J Surg; 1978 Jun; 48(3):296-300. PubMed ID: 281221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of a hamster melanoma with intralesional Corynebacterium granulosum.
    Paslin D
    Br J Dermatol; 1976 Jun; 94(6):639-44. PubMed ID: 949459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active immunotherapy with Corynebacterium parvum and chemotherapy in murine fibrosarcomas.
    Currie GA
    Br Med J; 1970 Feb; 1(5695):541-4. PubMed ID: 5435189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings: Immunotherapy of Moloney sarcoma virus tumours in mice with Corynebacterium parvum.
    Hamilton DN; Bell PR
    Br J Surg; 1974 Apr; 61(4):321. PubMed ID: 4832648
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatic arterial infusion of Corynebacterium parvum and chemotherapy.
    Patt YZ; Wallace S; Hersh EM; Hall SW; Menachem YB; Granmayeh M; McBride CM; Benjamin RS; Mavligit GM
    Surg Gynecol Obstet; 1978 Dec; 147(6):897-902. PubMed ID: 152477
    [No Abstract]   [Full Text] [Related]  

  • 20. Intralesional immunotherapy of brain tumors with combined Corynebacterium parvum and recombinant interleukin-2 in mice.
    Conley FK; Adler JR; Duncan JA; Kennedy JD; Sutton RC
    J Natl Cancer Inst; 1990 Aug; 82(16):1340-4. PubMed ID: 2380991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.